Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs Trade Desk Inc (TTD) Price & Performance

Quest Diagnostics IncTrade
Trade Desk IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs Trade Desk Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Trade Desk Inc trades at $13.5 (market cap $6.37B). The key difference: Quest Diagnostics Inc is far larger — about 4.1× Trade Desk Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.

DGXTTD
Market Cap
$26.21B$6.37B
Sector
HealthTechnology
52-Week High
$238.50$55.36
52-Week Low
$173.49$13.39
Enterprise Value
$31.97B$5.32B
Dividend Yield
1.45%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About Trade Desk Inc

The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.

Read more on TTD